Pascal Kaeser

Pascal Kaeser, M.D.

Professor of Neurobiology, Harvard Medical School

Our goal is to understand molecular mechanisms that underlie functions and plasticity of release sites for neurotransmitters and neuromodulators. Neurons predominantly communicate through fast neurotransmission at synapses. Synaptic and neuronal activity levels are tightly controlled, and adjusted to changes in demand. Prominent cellular events that underlie these adaptations are synaptic plasticity and neuromodulation via release of non-classical transmitters. My laboratory is interested in molecular mechanisms at presynaptic neurotransmitter release sites that participate in controlling neuronal activity, and we pursue two missions. (1) It is known that synaptic vesicles containing neurotransmitters fuse exclusively at hot spots for release in presynaptic nerve terminals called active zones. Active zones are fascinating molecular machines that consist of a complex network of multi-domain proteins, orchestrating the ultrafast membrane trafficking process required for synaptic transmission. We are investigating the composition of active zones, how they operate, how they change during plasticity and learning, and how these changes tune behaviors. (2) Neuronal activity is regulated by an intriguing variety of non-classical neurotransmitters called neuromodulators. Prominent neuromodulatory substances include a multitude of neuropeptides, monoamines such as dopamine, and neurotrophins. The machinery that mediates their release, however, is poorly understood. We are dissecting the molecular apparatus that controls release of dopamine, which will reveal general mechanisms of neuromodulation. Understanding dopamine release will also provide a molecular framework to investigate aspects of neuro-psychiatric disorders. Studies in my laboratory are founded on molecular and biochemical methods to identify novel components and protein interactions at neuronal release sites. We employ techniques ranging from conditional gene targeting in mice to electrophysiological and optogenetic analyses of synaptic activity to dissect their roles.

"My laboratory is interested in molecular mechanisms at presynaptic neurotransmitter release sites that participate in controlling neuronal activity."

Publications View
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning.
Authors: Authors: Tsetsenis T, Younts TJ, Chiu CQ, Kaeser PS, Castillo PE, Südhof TC.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Pushing synaptic vesicles over the RIM.
Authors: Authors: Kaeser PS.
Cell Logist
View full abstract on Pubmed
RIM proteins activate vesicle priming by reversing autoinhibitory homodimerization of Munc13.
Authors: Authors: Deng L, Kaeser PS, Xu W, Südhof TC.
Neuron
View full abstract on Pubmed
RIM determines Ca²+ channel density and vesicle docking at the presynaptic active zone.
Authors: Authors: Han Y, Kaeser PS, Südhof TC, Schneggenburger R.
Neuron
View full abstract on Pubmed
RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction.
Authors: Authors: Kaeser PS, Deng L, Wang Y, Dulubova I, Liu X, Rizo J, Südhof TC.
Cell
View full abstract on Pubmed
RIM1alpha and interacting proteins involved in presynaptic plasticity mediate prepulse inhibition and additional behaviors linked to schizophrenia.
Authors: Authors: Blundell J, Kaeser PS, Südhof TC, Powell CM.
J Neurosci
View full abstract on Pubmed
ELKS2alpha/CAST deletion selectively increases neurotransmitter release at inhibitory synapses.
Authors: Authors: Kaeser PS, Deng L, Chávez AE, Liu X, Castillo PE, Südhof TC.
Neuron
View full abstract on Pubmed
RIM1alpha and RIM1beta are synthesized from distinct promoters of the RIM1 gene to mediate differential but overlapping synaptic functions.
Authors: Authors: Kaeser PS, Kwon HB, Chiu CQ, Deng L, Castillo PE, Südhof TC.
J Neurosci
View full abstract on Pubmed
RIM1alpha phosphorylation at serine-413 by protein kinase A is not required for presynaptic long-term plasticity or learning.
Authors: Authors: Kaeser PS, Kwon HB, Blundell J, Chevaleyre V, Morishita W, Malenka RC, Powell CM, Castillo PE, Südhof TC.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha.
Authors: Authors: Chevaleyre V, Heifets BD, Kaeser PS, Südhof TC, Purpura DP, Castillo PE.
Neuron
View full abstract on Pubmed